Head of Investor Relations
BridgeBio Pharma, Inc. (BBIO)Equibles does not estimate personal net worth.
Get an email with a short summary when BridgeBio Pharma, Inc. publishes a filing, an earnings call transcript or a press release.
Get BBIO alertsPablo Alvira is recorded as Head of Investor Relations at BridgeBio Pharma, Inc. (BBIO). Pablo Alvira has spoken on 1 earnings call across 1 company, most recently for BridgeBio Pharma, Inc. on October 29, 2026. BridgeBio Pharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BridgeBio Pharma, Inc. includes Neil Kumar (CEO and Board Member), Charles Homcy (Chairman and Board Member), Brian Stephenson (CFO) and 7 others.
“Good afternoon, everyone, and thank you for joining Bridge BioPharma's third quarter 2026 earnings call. I am Chinmay Shukla, Chief Business Officer. With me today are Neil Kumar, our CEO, Matt Outen, our Chief Commercial Officer, and Tom Tramarki, our President and Chief Financial Officer.”
Biotechnology · Healthcare
Head of Investor Relations
